Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 6
2022 14
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.
Assawakosri S, Kanokudom S, Suntronwong N, Auphimai C, Nilyanimit P, Vichaiwattana P, Thongmee T, Duangchinda T, Chantima W, Pakchotanon P, Srimuan D, Thatsanatorn T, Klinfueng S, Yorsaeng R, Sudhinaraset N, Wanlapakorn N, Mongkolsapaya J, Honsawek S, Poovorawan Y. Assawakosri S, et al. Among authors: sudhinaraset n. J Infect Dis. 2022 Oct 17;226(8):1372-1381. doi: 10.1093/infdis/jiac092. J Infect Dis. 2022. PMID: 35267040
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine.
Kanokudom S, Assawakosri S, Suntronwong N, Auphimai C, Nilyanimit P, Vichaiwattana P, Thongmee T, Yorsaeng R, Srimuan D, Thatsanatorn T, Klinfueng S, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y. Kanokudom S, et al. Among authors: sudhinaraset n. Vaccines (Basel). 2022 Jan 6;10(1):86. doi: 10.3390/vaccines10010086. Vaccines (Basel). 2022. PMID: 35062747 Free PMC article.
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Wanlapakorn N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, Thongmee T, Vichaiwattana P, Auphimai C, Wongsrisang L, Klinfueng S, Sudhinaraset N, Poovorawan Y. Wanlapakorn N, et al. Among authors: sudhinaraset n. Vaccine. 2022 May 20;40(23):3203-3209. doi: 10.1016/j.vaccine.2022.04.043. Epub 2022 Apr 18. Vaccine. 2022. PMID: 35465981 Free PMC article.
Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients.
Chansaenroj J, Yorsaeng R, Posuwan N, Puenpa J, Wanlapakorn N, Sudhinaraset N, Sripramote M, Chalongviriyalert P, Jirajariyavej S, Kiatpanabhikul P, Saiyarin J, Soudon C, Thienfaidee O, Palakawong Na Ayuthaya T, Brukesawan C, Chirathaworn C, Intharasongkroh D, Chaiwanichsiri D, Issarasongkhram M, Kitphati R, Mungaomklang A, Nagavajara P, Poovorawan Y. Chansaenroj J, et al. Among authors: sudhinaraset n. Sci Rep. 2021 Dec 1;11(1):23216. doi: 10.1038/s41598-021-02659-4. Sci Rep. 2021. PMID: 34853374 Free PMC article.
The impact of COVID-19 and control measures on public health in Thailand, 2020.
Yorsaeng R, Suntronwong N, Thongpan I, Chuchaona W, Lestari FB, Pasittungkul S, Puenpa J, Atsawawaranunt K, Sharma C, Sudhinaraset N, Mungaomklang A, Kitphati R, Wanlapakorn N, Poovorawan Y. Yorsaeng R, et al. Among authors: sudhinaraset n. PeerJ. 2022 Feb 16;10:e12960. doi: 10.7717/peerj.12960. eCollection 2022. PeerJ. 2022. PMID: 35190788 Free PMC article.
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Kanokudom S, Assawakosri S, Suntronwong N, Chansaenroj J, Auphimai C, Nilyanimit P, Vichaiwattana P, Thongmee T, Yorsaeng R, Duangchinda T, Chantima W, Pakchotanon P, Srimuan D, Thatsanatorn T, Klinfueng S, Mongkolsapaya J, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y. Kanokudom S, et al. Among authors: sudhinaraset n. Vaccine. 2022 Sep 16;40(39):5657-5663. doi: 10.1016/j.vaccine.2022.08.033. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36031500 Free PMC article.
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults.
Yorsaeng R, Suntronwong N, Phowatthanasathian H, Assawakosri S, Kanokudom S, Thongmee T, Vichaiwattana P, Auphimai C, Wongsrisang L, Srimuan D, Thatsanatorn T, Klinfueng S, Sudhinaraset N, Wanlapakorn N, Poovorawan Y. Yorsaeng R, et al. Among authors: sudhinaraset n. Vaccine. 2022 Jan 24;40(3):524-530. doi: 10.1016/j.vaccine.2021.11.083. Epub 2021 Dec 3. Vaccine. 2022. PMID: 34893344 Free PMC article.
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
Suntronwong N, Assawakosri S, Kanokudom S, Yorsaeng R, Auphimai C, Thongmee T, Vichaiwattana P, Duangchinda T, Chantima W, Pakchotanon P, Chansaenroj J, Nilyanimit P, Srimuan D, Thatsanatorn T, Sudhinaraset N, Wanlapakorn N, Mongkolsapaya J, Poovorawan Y. Suntronwong N, et al. Among authors: sudhinaraset n. Diagnostics (Basel). 2022 Jul 22;12(8):1781. doi: 10.3390/diagnostics12081781. Diagnostics (Basel). 2022. PMID: 35892491 Free PMC article.
19 results